Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient

I Siddiqui, M Erreni, M van Brakel, R Debets… - … for immunotherapy of …, 2016 - Springer
Background Adoptive T-cell based immunotherapies constitute a promising approach to
treat cancer, however, a major problem is to obtain effective and long-lasting anti-tumor …

Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells

H Xin, T Kikuchi, S Andarini, S Ohkouchi… - European journal of …, 2005 - Wiley Online Library
The CX3C chemokine fractalkine (CX3CL1) exists as both a membrane‐bound form
promoting firm cell‐cell adhesion and a soluble form chemoattracting leukocytes expressing …

Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors

M Nukiwa, S Andarini, J Zaini, H Xin… - European journal of …, 2006 - Wiley Online Library
Abstract Fractalkine (CX3CL1) is a unique membrane‐bound CX3C chemokine that serves
as a potent chemoattractant for lymphocytes. The hypothesis of this study is that dendritic …

Fractalkine (CX3CL1)–and interleukin-2–enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells

Y Zeng, N Huebener, S Fest, S Weixler, U Schroeder… - Cancer research, 2007 - AACR
Fractalkine (FKN) is a unique CX3C chemokine (CX3CL1) known to induce both adhesion
and migration of leukocytes mediated by a membrane-bound and a soluble form …

Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma

L Tang, HD Hu, P Hu, YH Lan, ML Peng, M Chen… - Gene therapy, 2007 - nature.com
Abstract CX3CL1/Fractalkine (FK), a chemokine existing in both secreted and membrane
anchored form, was reported to induce suppressive activities in tumor models. Here, we …

[HTML][HTML] Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo

JY Kee, Y Arita, K Shinohara… - Molecular and …, 2013 - spandidos-publications.com
Due to their chemoattractant properties stimulating the accumulation of infiltrating immune
cells in tumors, chemokines are known to have antitumor effects. Fractalkine, a unique …

Fractalkine Mediates Natural Killer-Dependent Antitumor Responses in Vivo

E Lavergne, B Combadière, O Bonduelle, M Iga… - Cancer research, 2003 - AACR
CX3CR1 has been described previously as a marker of human cytotoxic effector cells. We
evaluated the possibility of using its ligand, CX3CL1, to redirect immune response against …

The fractalkine-receptor axis improves human colorectal cancer prognosis by limiting tumor metastatic dissemination

M Erreni, I Siddiqui, G Marelli, F Grizzi… - The Journal of …, 2016 - journals.aai.org
Human colorectal cancer (CRC) is a frequent neoplasia in Western countries, and its
metastatic progression is a major cause of cancer-related death. In search of specific …

Defective antitumor responses in CX3CR1‐deficient mice

YRA Yu, AM Fong, C Combadiere… - … journal of cancer, 2007 - Wiley Online Library
Innate immunity is critically important for tumor surveillance and regulating tumor metastasis.
Fractalkine (FKN, CX3CL1), operating through the receptor CX3CR1, is an effective …

The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells

I Nevo, O Sagi-Assif, T Meshel, A Ben-Baruch, K Jöhrer… - Cancer letters, 2009 - Elsevier
Transendothelial migration (TEM) of tumor cells is a crucial step in metastasis formation. The
prevailing paradigm is that the mechanism underlying TEM of tumor cells is similar to that of …